Literature DB >> 31161410

miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.

Chuanshan Zang1, Jian Sun2, Wenyi Liu3, Chunqin Chu3, Liwei Jiang1, Ruifeng Ge1.   

Abstract

Papillary thyroid carcinoma (PTC) is the main kind of thyroid carcinoma, most of which are diagnosed in women. MiR-21 has been reported to be upregulated in multiple cancers to effect tumor growth. However, the role of miR-21 in PTC development remains unclear. In this present study, miR-21 and VHL expressions in PTC tissues and cells were evaluated by RT-qPCR and/or western blot. MTT assay and transwell assay were employed to assess cell proliferative and invasive abilities, respectively. Luciferase reporter assay was carried out to identify the target of miR-21and explore its roles in PTC. MiR-21 was upregulated in PTC tissues and cells. Ectopic of miR-21 expression promoted cell proliferative and invasive abilities, while knockdown miR-21 suppressed these in TPC-1 and BCPAP cells. Overexpression of miR-21 predicted poor prognosis in PTC. What is more, luciferase reporter assays showed miR-21 can directly target VHL in PTC cells. Knockdown of miR-21 expression inhibited TPC-1 and BCPAP cell invasion-mediated EMT and proliferation through the PI3K/AKT pathway. In addition, VHL reverses partial function of miR-21 on PTC cell proliferation and invasion. MiR-21 can inhibit cell proliferation and invasion by regulated VHL in PTC cells. The newly identified miR-21/VHL axis might provide a novel insight into the pathogenesis and therapy of PTC.

Entities:  

Keywords:  EMT; Invasion; Papillary thyroid carcinoma; VHL; miR-21

Mesh:

Substances:

Year:  2019        PMID: 31161410     DOI: 10.1007/s13577-019-00254-4

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  28 in total

1.  Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas.

Authors:  Kai-Liang Zhang; Lei Han; Lu-Yue Chen; Zhen-Dong Shi; Ming Yang; Yu Ren; Ling-Chao Chen; Jun-Xia Zhang; Pei-Yu Pu; Chun-Sheng Kang
Journal:  Cancer Lett       Date:  2013-09-03       Impact factor: 8.679

2.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

Review 3.  Thyroid cancer gender disparity.

Authors:  Reza Rahbari; Lisa Zhang; Electron Kebebew
Journal:  Future Oncol       Date:  2010-11       Impact factor: 3.404

4.  von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.

Authors:  M A Hoffman; M Ohh; H Yang; J M Klco; M Ivan; W G Kaelin
Journal:  Hum Mol Genet       Date:  2001-05-01       Impact factor: 6.150

5.  N-ras mutation in poorly differentiated thyroid carcinomas: correlation with bone metastases and inverse correlation to thyroglobulin expression.

Authors:  F Basolo; F Pisaturo; L E Pollina; G Fontanini; R Elisei; E Molinaro; P Iacconi; P Miccoli; F Pacini
Journal:  Thyroid       Date:  2000-01       Impact factor: 6.568

6.  Upregulation of miR-21 by Ras in vivo and its role in tumor growth.

Authors:  D Frezzetti; M De Menna; P Zoppoli; C Guerra; A Ferraro; A M Bello; P De Luca; C Calabrese; A Fusco; M Ceccarelli; M Zollo; M Barbacid; R Di Lauro; G De Vita
Journal:  Oncogene       Date:  2010-10-18       Impact factor: 9.867

7.  Gender is an age-specific effect modifier for papillary cancers of the thyroid gland.

Authors:  Briseis A Kilfoy; Susan S Devesa; Mary H Ward; Yawei Zhang; Philip S Rosenberg; Theodore R Holford; William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-17       Impact factor: 4.254

Review 8.  The von Hippel-Lindau tumor suppressor gene and kidney cancer.

Authors:  William G Kaelin
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

9.  Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.

Authors:  Ya-Hui Huang; Yang-Hsiang Lin; Hsiang-Cheng Chi; Chen-Hsin Liao; Chia-Jung Liao; Sheng-Ming Wu; Cheng-Yi Chen; Yi-Hsin Tseng; Chung-Ying Tsai; Sheng-Yen Lin; Yu-Ting Hung; Chih-Jen Wang; Crystal D Lin; Kwang-Huei Lin
Journal:  Cancer Res       Date:  2013-02-26       Impact factor: 12.701

Review 10.  Adult-specific functions of animal microRNAs.

Authors:  Kailiang Sun; Eric C Lai
Journal:  Nat Rev Genet       Date:  2013-07-02       Impact factor: 53.242

View more
  6 in total

1.  Circ_0001658 regulates PI3K/AKT signaling via the miR-671-5p/ITGA2 axis and affects the progress of papillary thyroid carcinoma.

Authors:  Xiaoyu Liu; Congren Wang; Zijian Su; Shaoyang Cai; Qunxiong Pan; Xiangjin Chen
Journal:  Ann Transl Med       Date:  2022-09

2.  The Protective Role of pVHL in Imiquimod-Induced Psoriasis-like Skin Inflammation.

Authors:  Isaí Martínez-Torres; Araceli Tepale-Segura; Octavio Castro-Escamilla; Juan Carlos Cancino-Diaz; Sandra Rodríguez-Martínez; Sonia Mayra Perez-Tapia; Laura C Bonifaz; Mario Eugenio Cancino-Diaz
Journal:  Int J Mol Sci       Date:  2022-05-07       Impact factor: 6.208

Review 3.  MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.

Authors:  Adriana Fodor; Andrada Luciana Lazar; Cristina Buchman; Brandusa Tiperciuc; Olga Hilda Orasan; Angela Cozma
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

4.  Papillary Thyroid Carcinoma: Molecular Distinction by MicroRNA Profiling.

Authors:  Francesca Galuppini; Simona Censi; Isabella Merante Boschin; Matteo Fassan; Marta Sbaraglia; Nicola Valeri; Jens Claus Hahne; Loris Bertazza; Giada Munari; Marco Galasso; Luciano Cascione; Susi Barollo; Massimo Rugge; Federica Vianello; Angelo Paolo Dei Tos; Caterina Mian; Gianmaria Pennelli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-23       Impact factor: 5.555

5.  Papillary Thyroid Carcinoma Tissue miR-146b, -21, -221, -222, -181b Expression in Relation with Clinicopathological Features.

Authors:  Aistė Kondrotienė; Albertas Daukša; Daina Pamedytytė; Mintautė Kazokaitė; Aurelija Žvirblienė; Dalia Daukšienė; Vaida Simanavičienė; Raimonda Klimaitė; Ieva Golubickaitė; Rytis Stakaitis; Valdas Šarauskas; Rasa Verkauskienė; Birutė Žilaitienė
Journal:  Diagnostics (Basel)       Date:  2021-03-02

6.  Identification of candidate genes associated with papillary thyroid carcinoma pathogenesis and progression by weighted gene co-expression network analysis.

Authors:  Xiaomin Chen; Ruoyu Wang; Tianze Xu; Yajing Zhang; Hongyan Li; Chengcheng Du; Kun Wang; Zairong Gao
Journal:  Transl Cancer Res       Date:  2021-02       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.